An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies
NACompletedINTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
Herpes SimplexHIV Infections
Interventions
DRUG
Foscarnet sodium
Trial Locations (1)
77004
Foscarnet Research Program / Park Plaza Hosp, Houston
NCT00002272 - An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies | Biotech Hunter | Biotech Hunter